Pharma Focus Europe
ThermoFisher Scientific - Go beyond the catalog

Linnea SA of Switzerland and State University of Campinas (Unicamp) in Brazil Form Strategic Alliance to Advance Cannabinoid Research

Wednesday, February 07, 2024

Linnea SA, a distinguished global manufacturer of Active Pharmaceutical Ingredients, with over four decades of experience and a well-established presence in the Latin American region, is thrilled to announce the initiation of a strategic partnership with the State University of Campinas (UniCamp), a prestigious public research institution situated in São Paulo, Brazil. This significant collaboration aims to accelerate and enhance scientific exploration and research into cannabinoids.

The market for cannabinoids in Latin America has witnessed substantial growth in recent years, driven by the increasing demand from patients seeking safe, reliable, and effective therapeutic options. Current methods of cannabinoid administration often do not meet the rigorous quality standards typical of the pharmaceutical industry, which are essential for ensuring patient safety and efficacy.

As the demand for cannabinoid therapies continues to rise, regulatory authorities are gradually establishing guidelines to protect consumers and assist healthcare professionals in identifying the most suitable cannabinoid treatments.

To expedite this process, Linnea SA and UniCamp are working together to develop innovative cannabinoid-based products that meet current and future medical needs. Both organizations firmly believe that advancing science through the provision of high-quality products can significantly improve patient care.

Linnea SA currently supplies its botanically derived APIs, including cannabinoids, to more than 300 business partners across over 70 countries worldwide. The company is dedicated to upholding best practices and is deeply committed to ongoing scientific research and development through strategic global partnerships.

UniCamp is a highly regarded research institution, responsible for approximately 15% of Brazilian research output and producing more patents than any other research organization in Brazil.

 

Source: globenewswire.com

Latest Issue
Get instant
access to our latest e-book
Lab Indonesia 2024Sartorius Lab Balance CleaningWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies 2024Equinix accelerated medical research...World Vaccine Congress Washington 2024EUROPEAN PHARMA OUTSOURCING SUMMIT 2024Pharma 2024